In vivo and in vitro action of dexamethasone on adhesion between PBMNCs and endothelial cells

M. Gelati, E. Ciusani, A. Dufour, E. Corsini, G. Massa, C. Milanese, A. Nespolo, A. Salmaggi

Research output: Contribution to journalArticle

Abstract

Dexamethasone (Dx) is a synthetic steroid commonly used in the acute phases of multiple sclerosis (MS). It has a wide spectrum of activity on immune cells, it may also act on endothelial cells preventing mononuclear cell/endothelium adhesion. The authors studied the in vitro adhesion of PBMNCs (CD4+, CD8+) from eight healthy controls to endothelial monolayers pre-stimulated with Dx, γ-IFN, or both. The effects of Dx in vitro on endothelial cells did not counteract γ-IFN-induced enhanced adhesion of control PBMNCs. Adhesion phenomena were also studied between cultured human umbilical vein endothelial cells (HUVECs) and PBMNCs (CD45+, CD14+) from six MS patients treated in vivo with Dx (8 mg, intravenously). After the in vivo Dx treatment, PBMNC adhesion to endothelium decreased at 3 h, particularly for CD14+ cells, while after 24 h the adhesion was higher, but not significantly different from the baseline level in stimulated or unstimulated HUVECs. The lack of efficacy of in vitro Dx treatment of HUVECs in modulation of PBMNCs, as opposed to in vitro-Dx-induced changes in PBMNCs adhesion, suggests that under our experimental conditions Dx exerts its modulating activity on adhesive processes mainly via direct or indirect action on circulating immunocytes.

Original languageEnglish
Pages (from-to)63-72
Number of pages10
JournalInternational Journal of Immunotherapy
Volume12
Issue number3-4
Publication statusPublished - 1996

Fingerprint

Dexamethasone
Endothelial Cells
Human Umbilical Vein Endothelial Cells
Multiple Sclerosis
Endothelium
In Vitro Techniques
Cell Adhesion
Adhesives
Steroids
Therapeutics

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

In vivo and in vitro action of dexamethasone on adhesion between PBMNCs and endothelial cells. / Gelati, M.; Ciusani, E.; Dufour, A.; Corsini, E.; Massa, G.; Milanese, C.; Nespolo, A.; Salmaggi, A.

In: International Journal of Immunotherapy, Vol. 12, No. 3-4, 1996, p. 63-72.

Research output: Contribution to journalArticle

Gelati, M. ; Ciusani, E. ; Dufour, A. ; Corsini, E. ; Massa, G. ; Milanese, C. ; Nespolo, A. ; Salmaggi, A. / In vivo and in vitro action of dexamethasone on adhesion between PBMNCs and endothelial cells. In: International Journal of Immunotherapy. 1996 ; Vol. 12, No. 3-4. pp. 63-72.
@article{4c02fe86a46f46e2aa3ac78075289799,
title = "In vivo and in vitro action of dexamethasone on adhesion between PBMNCs and endothelial cells",
abstract = "Dexamethasone (Dx) is a synthetic steroid commonly used in the acute phases of multiple sclerosis (MS). It has a wide spectrum of activity on immune cells, it may also act on endothelial cells preventing mononuclear cell/endothelium adhesion. The authors studied the in vitro adhesion of PBMNCs (CD4+, CD8+) from eight healthy controls to endothelial monolayers pre-stimulated with Dx, γ-IFN, or both. The effects of Dx in vitro on endothelial cells did not counteract γ-IFN-induced enhanced adhesion of control PBMNCs. Adhesion phenomena were also studied between cultured human umbilical vein endothelial cells (HUVECs) and PBMNCs (CD45+, CD14+) from six MS patients treated in vivo with Dx (8 mg, intravenously). After the in vivo Dx treatment, PBMNC adhesion to endothelium decreased at 3 h, particularly for CD14+ cells, while after 24 h the adhesion was higher, but not significantly different from the baseline level in stimulated or unstimulated HUVECs. The lack of efficacy of in vitro Dx treatment of HUVECs in modulation of PBMNCs, as opposed to in vitro-Dx-induced changes in PBMNCs adhesion, suggests that under our experimental conditions Dx exerts its modulating activity on adhesive processes mainly via direct or indirect action on circulating immunocytes.",
author = "M. Gelati and E. Ciusani and A. Dufour and E. Corsini and G. Massa and C. Milanese and A. Nespolo and A. Salmaggi",
year = "1996",
language = "English",
volume = "12",
pages = "63--72",
journal = "International Journal of Immunotherapy",
issn = "0255-9625",
publisher = "Bioscience Ediprint Inc.",
number = "3-4",

}

TY - JOUR

T1 - In vivo and in vitro action of dexamethasone on adhesion between PBMNCs and endothelial cells

AU - Gelati, M.

AU - Ciusani, E.

AU - Dufour, A.

AU - Corsini, E.

AU - Massa, G.

AU - Milanese, C.

AU - Nespolo, A.

AU - Salmaggi, A.

PY - 1996

Y1 - 1996

N2 - Dexamethasone (Dx) is a synthetic steroid commonly used in the acute phases of multiple sclerosis (MS). It has a wide spectrum of activity on immune cells, it may also act on endothelial cells preventing mononuclear cell/endothelium adhesion. The authors studied the in vitro adhesion of PBMNCs (CD4+, CD8+) from eight healthy controls to endothelial monolayers pre-stimulated with Dx, γ-IFN, or both. The effects of Dx in vitro on endothelial cells did not counteract γ-IFN-induced enhanced adhesion of control PBMNCs. Adhesion phenomena were also studied between cultured human umbilical vein endothelial cells (HUVECs) and PBMNCs (CD45+, CD14+) from six MS patients treated in vivo with Dx (8 mg, intravenously). After the in vivo Dx treatment, PBMNC adhesion to endothelium decreased at 3 h, particularly for CD14+ cells, while after 24 h the adhesion was higher, but not significantly different from the baseline level in stimulated or unstimulated HUVECs. The lack of efficacy of in vitro Dx treatment of HUVECs in modulation of PBMNCs, as opposed to in vitro-Dx-induced changes in PBMNCs adhesion, suggests that under our experimental conditions Dx exerts its modulating activity on adhesive processes mainly via direct or indirect action on circulating immunocytes.

AB - Dexamethasone (Dx) is a synthetic steroid commonly used in the acute phases of multiple sclerosis (MS). It has a wide spectrum of activity on immune cells, it may also act on endothelial cells preventing mononuclear cell/endothelium adhesion. The authors studied the in vitro adhesion of PBMNCs (CD4+, CD8+) from eight healthy controls to endothelial monolayers pre-stimulated with Dx, γ-IFN, or both. The effects of Dx in vitro on endothelial cells did not counteract γ-IFN-induced enhanced adhesion of control PBMNCs. Adhesion phenomena were also studied between cultured human umbilical vein endothelial cells (HUVECs) and PBMNCs (CD45+, CD14+) from six MS patients treated in vivo with Dx (8 mg, intravenously). After the in vivo Dx treatment, PBMNC adhesion to endothelium decreased at 3 h, particularly for CD14+ cells, while after 24 h the adhesion was higher, but not significantly different from the baseline level in stimulated or unstimulated HUVECs. The lack of efficacy of in vitro Dx treatment of HUVECs in modulation of PBMNCs, as opposed to in vitro-Dx-induced changes in PBMNCs adhesion, suggests that under our experimental conditions Dx exerts its modulating activity on adhesive processes mainly via direct or indirect action on circulating immunocytes.

UR - http://www.scopus.com/inward/record.url?scp=0030389775&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030389775&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0030389775

VL - 12

SP - 63

EP - 72

JO - International Journal of Immunotherapy

JF - International Journal of Immunotherapy

SN - 0255-9625

IS - 3-4

ER -